Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion type Assertion NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_head.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion description "[Secondary outcomes included progression to CDR at least 0�5, symptomatic Alzheimer's disease (score of at least 0�5 for memory and at least one other domain and cognitive impairments deemed to be due to Alzheimer's disease), and mortality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_provenance.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion evidence source_evidence_literature NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_provenance.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion SIO_000772 24012374 NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_provenance.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion wasDerivedFrom befree-20140225 NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_provenance.
- NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_assertion wasGeneratedBy ECO_0000203 NP880006.RAyJtcFk4nXyNXsRu0G81Jxb4qBYR3KpNu5ANQmIyq7EQ130_provenance.